Medway Community Healthcare Medway NHS Trust Foundation Trust
Medway Clinical Commissioning Group Swale Clinical Commissioning Group

9. Blood and Nutrition - guidance

To access BNF Formulary section click on the link under BNF Section/s

To access the Guidance Document click on the highlighted text under the Title column

Use documents past their review date with Caution

BNF Section/s Title Issuing Body  Date of Issue Update Due
9.1.4 Avatrombopag  High-Cost Drugs    
9.1.4 Avatrombopag - Avatrombopag for treating primary chronic immune thrombocytopenia NICE TA853 NICE Dec 2022  
9.3.1 Carnitine  High-Cost Drugs    
9.1.4 Fostamatinib  High-Cost Drugs    
9.1.4 Fostamatinib - Fostamatinib for treating refractory chronic immune thrombocytopenia TA835 NICE Oct 2022  
9 Forceval - Kent and Medway ICB Forceval - Position Statement for Primary Care Kent and Medway ICB  Dec 2023 Dec 2025
 9.2.4 Hypomagnesaemia - Hypomagnesaemia in Adults – Primary Care Guide Kent and Medway ICB  Aug 2023  Aug 2025 
9.2.6.1 Patiromer (Veltassa) - Patiromer for treating hyperkalaemia - TA623 NICE  Feb 2020 2023
9.1.1 Roxadustat High-Cost Drugs    
9.1.1 Roxadustat (Evrenzo) - Roxadustat for treating symptomatic anaemia in chronic kidney disease TA807  NICE  Jul 2022 -
9.2.6.1 Sodium zirconium (Lokelma) - Sodium zirconium cyclosilicate for treating hyperkalaemia -TA599 NICE Jan 2022 -
9.1.1.3 Vitamin B12 - Kent and Medway Vitamin B12 Position statement and deprescribing Kent and Medway ICB Jul 2023 Jul 2025
9.6 Vitamin D - KENT AND MEDWAY PRESCRIBING GUIDELINES FOR VITAMIN D IN ADULTS Kent and Medway CCG Dec 2020 -

 

 

 

  • First Line Choice
  • On Formulary
  • Specialist Initiation Only
  • Hospital Only
  • KMPT Initiation Only
  •